Dr Michael Dake reports on the new venous stent....this is a 1st step to developing and testing a venous stent for the jugular vein to treat CCSVI.
https://venousnews.com/vernacular-one-year-results/

? Michael D Dake (Tucson, USA) presented results from the VERNACULAR trial, which was designed to assess the performance of the Venovo venous stent (BD) for the treatment of iliac and femoral vein occlusions. At one year, the researchers found that the overall patency rate was more than 88%. Impor...